Effect of androgen deprivation therapy on prostatic intraepithelial neoplasia

Urology

Volumn 58, Issue 2 SUPPL. 1, 2001, Pages 91-93

  Bostwick, David G ^a,b,c   Qian, Junqi ^a  

^a BOSTWICK LABORATORIES   (United States)

^b Urology of Virginia   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; FINASTERIDE; STEROID 5ALPHA REDUCTASE;

CARCINOMA IN SITU; CHEMOPROPHYLAXIS; CONFERENCE PAPER; ENZYME INHIBITION; HISTOPATHOLOGY; HORMONE DEPENDENCE; HUMAN; MALE; PRIORITY JOURNAL; PROSTATIC INTRAEPITHELIAL NEOPLASIA;

ADENOCARCINOMA; ANDROGEN ANTAGONISTS; ANTINEOPLASTIC AGENTS, HORMONAL; CHEMOPREVENTION; DRUG ADMINISTRATION SCHEDULE; HUMANS; MALE; PRECANCEROUS CONDITIONS; PROSTATE; PROSTATIC INTRAEPITHELIAL NEOPLASIA;

EID: 0034908839     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(01)01248-1     Document Type: Conference Paper

References (30)

1. Intraductal dysplasia; a premalignant lesion of the prostate
2. High grade prostatic intraepithelial neoplasia; the most likely precursor of prostate cancer
3. The extent and multicentricity of high grade intraepithelial neoplasia in clinically localized prostatic adenocarcinoma
4. Prevalence of prostatic intraepithelial neoplasia (PIN) in biopsies from hospital practice and pilot screening; clinical implications
5. Evaluation of prostate needle biopsies in a population-based screening study; the impact of borderline lesions
6. The incidence of high grade prostatic intraepithelial neoplasia in needle biopsies
7. Extent and zonal distribution of prostatic intraepithelial neoplasia in patients with prostatic carcinoma in Japan; analysis of whole-mounted prostatectomy specimens
8. Architectural patterns of high grade prostatic intraepithelial neoplasia
9. Independent origin of multiple foci of prostatic intraepithelial neoplasia; comparison with matched foci of prostate carcinoma
10. Prostatic intraepithelial neoplasia is a risk factor for cancer
11. Clinical management of premalignant lesions of the prostate
12. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients
13. Epidemiology of high-grade prostatic intraepithelial neoplasia
14. The clinical significance of high-grade prostatic intraepithelial neoplasia in transurethral resection specimens
15. Incidence and clinical significance of high-grade prostatic intraepithelial neoplasia in TURP specimens
16. Effect of neoadjuvant hormonal therapy on prostatic intraepithelial neoplasia and its prognostic significance
17. Decrease of prostatic intraepithelial neoplasia (PIN) following androgen deprivation therapy in patients with stage T3 carcinoma treated by radical prostatectomy
18. Effect of neoadjuvant endocrine therapy (combined androgen blockade) on normal prostate and prostate carcinoma; a randomized study
19. Pathology of androgen deprivation therapy in prostate carcinoma; a comparative study of 173 patients
20. Pathological changes in prostate lesions after androgen manipulation
21. Persistence of high-grade prostatic intra-epithelial neoplasia under combined androgen blockade therapy
22. Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer
23. Chemoprevention for prostatic intraepithelial neoplasia
24. Does long-term finasteride therapy affect the histologic features of benign prostatic tissue and prostate cancer on needle biopsy?
25. The effect of finasteride on prostate gland peripheral zone histology and proliferation rates in men at high risk for prostate cancer
26. The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen levels
27. The most promising surrogate endpoint biomarkers for screening candidate chemopreventive compounds for prostatic adenocarcinoma in short-term phase II clinical trials
28. Androgen deprivation as a strategy for prostate cancer chemoprevention